Deep vein thrombosis
Deep vein thrombosis, or DVT, is a blood clot that forms in a vein deep in the body, most often in the lower leg or thigh. MedlinePlus says a deep vein clot can break loose and cause a serious problem in the lung called a pulmonary embolism, and that sitting still for a long time can make DVT more likely. It says treatment includes medicines to ease pain and inflammation, break up clots and keep new clots from forming. NHLBI adds that DVT can also form in the arms, particularly when a large intravenous line sits in the vein.
Also called DVT
- Condition
- In this atlas
Overview
Technical summary
MeSH D020246 is named Venous Thrombosis. It is wider than this record, so it is a broad match: its scope note covers a blood clot within any vein, and its narrower headings include Upper Extremity Deep Vein Thrombosis, Retinal Vein Occlusion and Budd-Chiari Syndrome. A list of trials matched by that heading can therefore include clots in veins that are not deep veins of the leg.
Recognition
MedlinePlus lists warmth and tenderness over the vein, pain or swelling in the part of the body affected, and skin redness as common symptoms.
Classification codes
-
D020246Venous Thrombosis
Burden
No burden claims are published.
Claims and evidence
Context People with deep vein thrombosis, pulmonary embolism, peripheral artery disease or pulmonary hypertension, as described in MedlinePlus and NHLBI patient pages
- Recipient
- Recipient not specified
- Population
- People with the condition each page covers. The pages give no age limits and no inclusion criteria.
- Care setting
- Not stated; patient information pages
- Geography
- Not stated; United States federal health agencies (NLM and NIH)
- Life stage
- Not stated on the pages
- Gestational age
- Not reported
- Postnatal age
- Not reported
- Follow-up
- Not applicable (descriptive pages)
Eligibility: inclusion criteria not stated; exclusion criteria not stated
- Included
- None stated
- Excluded
- None stated
MedlinePlus says a deep vein thrombosis can break loose and cause a serious problem in the lung, called a pulmonary embolism. It says most deep vein clots occur in the lower leg or thigh. NHLBI names the pelvis as a further site, and says DVT may also affect the arms, mainly when a big central line is placed in the vein.
Applies to Recipient not specified People with deep vein thrombosis, pulmonary embolism, peripheral artery disease or pulmonary hypertension, as described in MedlinePlus and NHLBI patient pages
- Certainty method
- Not assessed
- Limitations
- Patient-education pages from US government sources. They give no study, no size of risk and no population, and they do not say how often any of this happens. MeSH defines venous thrombosis as a clot within any vein, which is wider than the deep veins of the limbs.
- Last checked
- 2026-10-30
- Next evidence check due
- Not scheduled
Sources and citations (4)
-
Supports MedlinePlus health topic: Deep Vein Thrombosis
- Locator
- Summary, paragraph 1, sentence 4
- How it applies
- MedlinePlus: a deep vein clot can break loose and cause a lung problem.
- Retrieved
- Source effective date
- Not reported
- Source state
- Current
- Version fingerprint
5c66ceb976b99fc88f424d1802050dff8c3d915e8462c85cae24320f471b8a67- Reuse basis
- The MedlinePlus page on using its content (fetched 2026-10-30, sha256 e0fbefd889f779a2537ed84f7649157343e52043a577e2a21ddaf9c416844161, hash only) says works produced by the federal government are not copyrighted, and lists summaries on health topic pages and medical test information as public domain; A.D.A.M. Medical Encyclopedia articles are copyrighted, and this atlas cites none. Please acknowledge MedlinePlus, National Library of Medicine, as the source. The raw page is committed in the atlas repository; only the public-domain text is quoted. Terms re-checked on 2026-11-08 at https://medlineplus.gov/about/using/usingcontent/ (page not committed; sha256 0825c88f5bd1dade7c8693bad8035b0d1f25fd0b8c5053e488c618fb2b62e722). That page says health topic page summaries, medical test information and Genetics page summaries are in the public domain, and that A.D.A.M. Medical Encyclopedia content (medlineplus.gov/ency/), ASHP drug monographs and most images are copyrighted. This source is a public-domain page, not an A.D.A.M. page, so public text stays quote; any A.D.A.M. page would be cite_only.
-
Supports MedlinePlus health topic: Deep Vein Thrombosis
- Locator
- Summary, paragraph 1, sentence 2
- How it applies
- MedlinePlus: where most deep vein clots occur.
- Retrieved
- Source effective date
- Not reported
- Source state
- Current
- Version fingerprint
5c66ceb976b99fc88f424d1802050dff8c3d915e8462c85cae24320f471b8a67- Reuse basis
- The MedlinePlus page on using its content (fetched 2026-10-30, sha256 e0fbefd889f779a2537ed84f7649157343e52043a577e2a21ddaf9c416844161, hash only) says works produced by the federal government are not copyrighted, and lists summaries on health topic pages and medical test information as public domain; A.D.A.M. Medical Encyclopedia articles are copyrighted, and this atlas cites none. Please acknowledge MedlinePlus, National Library of Medicine, as the source. The raw page is committed in the atlas repository; only the public-domain text is quoted. Terms re-checked on 2026-11-08 at https://medlineplus.gov/about/using/usingcontent/ (page not committed; sha256 0825c88f5bd1dade7c8693bad8035b0d1f25fd0b8c5053e488c618fb2b62e722). That page says health topic page summaries, medical test information and Genetics page summaries are in the public domain, and that A.D.A.M. Medical Encyclopedia content (medlineplus.gov/ency/), ASHP drug monographs and most images are copyrighted. This source is a public-domain page, not an A.D.A.M. page, so public text stays quote; any A.D.A.M. page would be cite_only.
-
Supports Venous Thromboembolism: What Is Venous Thromboembolism? (NHLBI)
- Locator
- What Is Venous Thromboembolism?, paragraph 1
- How it applies
- NHLBI: usual places, and DVT in the arms with a central line. Last updated September 19, 2022 according to the page.
- Retrieved
- Source effective date
- Not reported
- Source state
- Current
- Version fingerprint
37fb21ae088794935949d603d3d1f376bbac96887402f47b8cf63dccf2839944- Reuse basis
- NHLBI is part of the U.S. National Institutes of Health. The pages carry third-party material, such as animations credited to Nucleus Medical Media, that this atlas does not use. NHLBI's own reuse terms were not read, so public text is cite_only until they are read; the rule can then change to quote. Hash only; the page is not committed.
-
Background MeSH scope note for descriptor D020246 (Venous Thrombosis)
- Locator
- scopeNote.@value
- How it applies
- MeSH scope note for the wider heading venous thrombosis.
- Retrieved
- Source effective date
- Not reported
- Source state
- Current
- Version fingerprint
86294fe7c1fdea426413be1ec11d9982a19aa21a5674d47ae08ff18fc33af8d3- Reuse basis
- The NLM web policies page (fetched 2026-10-30, sha256 c8b7026b5c3fcfd1b0cb88755077f6a99a5f2159eecd42b0e7d1a5ad9b30ec55, hash only) says works produced by the U.S. government are not subject to copyright protection in the United States and asks users to acknowledge NLM as the source. Source: National Library of Medicine. This copy was fetched on 2026-10-30 and may not reflect the most current data. The raw bytes are committed in the atlas repository.
Clinical links
Each link reports what one cited claim says about one population. "Evaluated for" means studied, not shown to work. These links do not show that anything is effective or right for you.
-
Claim, not a settled fact Evaluated for this: Fondaparinux
Applies to Adult Adults for whom the US label of fondaparinux (Arixtra) lists an indication: prophylaxis of deep vein thrombosis after hip fracture, hip replacement, knee replacement or abdominal surgery; treatment of deep vein thrombosis or acute pulmonary embolism
Population, setting and follow-up
- Adult patients described in the indications sections of the label.
- Prescription medicine, as described in the US label
- United States (label of the US Food and Drug Administration)
- Adults, as the passages read state
The US label of Arixtra (fondaparinux sodium), in the Mylan Institutional LLC version dated 2024-12-10 in openFDA, describes fondaparinux as a Factor Xa inhibitor (anticoagulant) and lists it, in adult patients, for the prophylaxis of deep vein thrombosis in patients undergoing hip fracture surgery, hip replacement surgery, knee replacement surgery or abdominal surgery, and for the treatment of deep vein thrombosis or acute pulmonary embolism when administered in conjunction with warfarin sodium. The label carries a boxed warning about epidural or spinal hematomas in anticoagulated patients who receive neuraxial anesthesia or undergo spinal puncture.Limitations. This claim records what the label says the medicine is indicated for in adults. It is not a finding about how well the medicine works, and no trial result is recorded for it in this atlas. The paediatric indication is recorded in a separate claim. Only the indications, the first sentence of the boxed warning and the mechanism sentence were read; contraindications, doses, interactions and other warnings were not recorded. Labels change, and openFDA also lists generic labels. openFDA's own disclaimer says not to rely on it for decisions about medical care.
-
Claim, not a settled fact Evaluated for this: Heparin
Applies to Recipient not specified People for whom the US label of heparin sodium injection lists an indication: venous thrombosis, pulmonary embolism, atrial fibrillation with embolization, consumptive coagulopathy, arterial and cardiac surgery, peripheral arterial embolism
Population, setting and follow-up
- Patients described in the indications section of the label. The label passages read do not state an age range.
- Prescription medicine, as described in the US label
- United States (label of the US Food and Drug Administration)
- Not stated in the label passages read
- Gestational age Not reported
- Postnatal age Not reported
The US label of Heparin Sodium Injection, in the Fresenius Kabi USA, LLC version dated 2026-04-30 in openFDA, describes heparin as an anticoagulant and lists it for the prophylaxis and treatment of venous thrombosis and pulmonary embolism; the prevention of postoperative deep venous thrombosis and pulmonary embolism in patients undergoing major abdominothoracic surgery or otherwise at risk of thromboembolic disease; atrial fibrillation with embolization; the treatment of acute and chronic consumptive coagulopathies (disseminated intravascular coagulation); the prevention of clotting in arterial and cardiac surgery; the prophylaxis and treatment of peripheral arterial embolism; and use as an anticoagulant in blood transfusions, extracorporeal circulation and dialysis procedures.Limitations. This claim records what the label says the medicine is indicated for. It is not a finding about how well the medicine works, and no trial result is recorded for it in this atlas. The label has no boxed warning section in openFDA; contraindications, doses, interactions, pregnancy and paediatric use and other warnings were not read. Labels differ between sponsors and change over time, and openFDA lists many heparin labels. openFDA's own disclaimer says not to rely on it for decisions about medical care.
-
Claim, not a settled fact Evaluated for this: D-dimer test
Applies to Recipient not specified People who may have a blood clotting disorder (MedlinePlus test page)
Population, setting and follow-up
- People who may have a blood clot, or who are being treated for a blood clotting disorder. The page lists deep vein thrombosis, pulmonary embolism, disseminated intravascular coagulation and stroke as conditions the test may be used for.
- A blood sample taken by a health care professional; the page also mentions imaging tests that may follow an abnormal result.
- Not stated. The source does not name a country.
- Not restricted by the page. It lists pregnancy and older age among reasons for a high result; this record makes no statement about pregnancy.
- Gestational age Not reported
- Postnatal age Not reported
MedlinePlus says a D-dimer test looks for a protein fragment made when a blood clot dissolves, and is used to check whether a person may have a blood clot and whether more tests for blood clotting disorders are needed. It lists deep vein thrombosis and pulmonary embolism among the disorders it may be used for. It says high D-dimer levels are not always caused by clotting disorders, and that blood thinner medicines may cause a false negative result.Limitations. General patient information from a government health page, not a diagnostic rule. The page gives no accuracy figures or study data. The page also lists disseminated intravascular coagulation and stroke, the other reasons for a high level, the imaging tests that may follow and the symptoms of clotting disorders; none of these is repeated here.
-
Claim, not a settled fact Evaluated for this: Vascular ultrasound (carotid and venous duplex)
Applies to Recipient not specified People who may have a blood flow condition (MedlinePlus test page and MeSH scope note)
Population, setting and follow-up
- People who have symptoms of abnormal blood flow or a condition that affects blood flow, as the MedlinePlus page describes them. This record uses only the statements about the arms, legs, neck and brain.
- A test done by a trained sonographer, as the page describes; the page also lists preparation and what happens during the test, which are not used.
- Not stated. The source does not name a country.
- Not restricted by the page, which also covers blood flow to the fetus in pregnancy. This record makes no statement about pregnancy or the fetus, newborns or children.
- Gestational age Not reported
- Postnatal age Not reported
MedlinePlus says a Doppler ultrasound is a type of ultrasound imaging test that uses sound waves to show how well blood flows through blood vessels, lists vascular ultrasound as another name, and describes duplex Doppler as using standard ultrasound to take images showing blood flow. It says a Doppler ultrasound of the arms and legs can help diagnose conditions that reduce blood flow, including deep vein thrombosis, peripheral arterial disease and varicose veins, and that one of the neck and brain can help look for conditions that affect blood flow to the brain, including carotid artery disease. MeSH describes duplex Doppler ultrasonography as applying the Doppler effect combined with real-time imaging, with the ability to estimate the velocity of flow.Limitations. General patient information and a vocabulary note, not a diagnostic rule. The page gives no accuracy figures or study data. Its statements on the heart, abdomen, transplanted organs and the fetus, its preparation and its results are not repeated; this record makes no statement about pregnancy.
Registry records
Assembled by a program from ClinicalTrials.gov. No person wrote or checked these pages, and they are counted apart from the pages that people wrote. Lists of trials come from the registry's own coding and may miss trials.
Registry trials 91
Record details
- Record id
cardio:deep-vein-thrombosis- Content hash
1c03e8f3403ac5581db99da7350dbebb99d945ec3fd533fae55237bf5ddb842a